GenSight Biologics gensight-biologics.com


Public list: Smart Money VCs (6327) Pharma Startups (4733)

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. To address these therapeutic areas, the company leverages its integrated development platform by combining a gene therapy-based approach with core technology platforms of mitochondrial targeting sequence, or MTS, and optogenetics.

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. To address these therapeutic areas, the company leverages ...Show all

Company (IPO / Went public)

Phone: +33 1 76 21 72 20

Fax:

74, rue du Faubourg Saint-Antoine

Paris, 75012
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
GenSight Biologics $121.6M Jul 13, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related GenSight Biologics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)